Tag: BA

New Options Ideas

FireEye, Inc. FEYE – Options Ideas

The first earnings play to catch our eye this morning is based off of the beat just posted by FEYE during aftermarket hours yesterday. The company’s earnings rose to a record high, and its Q2 revenues also registered as an all time quarterly high.

As a result, FEYE is looking attractive to us on a short and longer term basis. Accordingly, we are going to begin tracking a couple of different sets of ideas for the FEYE chain, the FEYE Weekly $14-15 Calls & 08/14 $15.50-16 Calls


More Options Ideas

The earnings calendar is jam packed once again, and here are a couple of the other big name reporters that are gaining our attention here in the premarket. Stocks in general are rising today in advance of the 2PM Fed Meeting.

BA Weekly $170-172.50 Calls
SHOP Weekly $1055-1065 Calls

Extended Watchlist:
KNOS, VYST, IGEN, LEAS, XTRM

Recent Performers

S&P 500 ETF Trust (SPY) – Recap

Our main winner from Friday morning’s premarket report was our idea for the SPY. The markets saw an early rip out of the gate before pulling back, running once again, and eventually tapering off into the close.

As a result of the activity we observed, our designated contract sets experienced two separate and significant surges on the day. Here are the total possible gains afforded by the moves that occurred:

SPY 07/02 $313-314 Calls
$313: 1.88-4.22 (+47%) | .67-1.55 (+47%)
$314: 1.28-2.10 (+49%) | .36-.77 (+47%)

Other Recent Winners:

Plug Power Inc. PLUG – We also want to begin this fresh trading week by re-highlighting PLUG, which we most recently talked about on June 24th. Subsequent to that report, the stock traded for as little as 6.91 a share, and on Friday the stock attained a new high of 9.65. This morning in the premarket we’ve seen shares change hands for 10.09.

That puts our total observed increase on PLUG in under two weeks at a respectable 46% and warrants further attention going forward.
____

Overstock.com Inc. OSTK – Another recent performer we’ve been hot on the trail of is OSTK, which we mentioned quite a bit back in May. Since then, OSTK has done little else other than climb its way to new highs week after week.

When we first alerted on OSTK it was trading at 15.45, and to close out the short week on Thursday, the stock had hit 39.38. That works out to a 2-month upswing of 155%

Extended Watchlist:
UBER, BA, UONEK, DUK, LMFA BLDP, FCEL, NIO, BLNK

Tons of Updates, New Ideas

Options Reviews

Our ideas in the Mastercard and Boeing chains from yesterday’s report both played out very nicely for us, producing sizable intraday gain opportunities for ourselves and our readers. Here are the gains that have been made so far.

MA Weekly $272.50-277.50 Calls
$272.50: 6.03-13.00 (+116%)
$275: 4.58-10.75 (+135%)
$277.50: 3.25-8.74 (+169%)

BA Weekly $138-140 Calls
$138: 2.57-10.39 (+304%)
$139: 2.25-9.68 (+330%)
$140: 1.82-9.13 (+402%)
_____

AMC Entertainment Holdings Inc. AMC – Update

We also got a new high in our AMC 06/19 $4 Calls, an options idea we formulated after our associate trader, Nicholas in VA, called our attention to the stock. These calls have now made a move .55-1.83 in just a couple of sessions, marking a total gain of 233%
_____

Fresh Ideas:
MSFT Weekly $177.50-180 Calls
TSLA $840-860 Calls
SPY 05/04 $291-288 Puts
MCD Weekly $185 Puts


Stock Updates

We also had a couple of stock calls from our extended watchlist produce some solid gain chances for us, which were as follows.

Ozop Surgical Corp. OZSC 
Range: .0133-.0247 – Total Gain: 86%

Transportation and Logistics Systems, Inc. TLSS
Range: .0421-.094  – Total Gain: 123%

Vaxart Inc. VXRT – News Alert

We’ve been tracking VXRT pretty closely in recent weeks, and wanted to include a lonk to the coronavirus news the company put out this morning, which points to the company possible making some headway in the fight to develop a vaccine. It’s sending the stock on a ride in the premarket, and keeping us on high alert.

SOUTH SAN FRANCISCO, Calif., April 30, 2020 (GLOBE NEWSWIRE) — Vaxart, Inc., a clinical-stage biotechnology company developing oral recombinant vaccines that are administered by tablet rather than by injection, today announced that it has obtained positive pre-clinical results for its COVID-19 vaccine candidates, with several of the vaccine candidates generating immune responses in all tested animals after a single dose.(>>View Full PR)